by The global Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1143.56 Mn or in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Dental membranes and bone graft substitutes are used in dental procedures to reconstruct defects of the alveolar bone and promote new bone formation. Such procedures help with dental implant placement and ridge augmentation.
Market key trends:
The dental membrane and bone graft substitute market is growing due to increasing demand for dental implants. Technological advancements in membrane and bone graft substitute materials is also fueling market growth. Newer synthetic and natural biomaterial options being developed to provide a conductive scaffold for bone regeneration with minimal immune response or risk of disease transmission. Bone morphogenic proteins are also being incorporated in graft materials to enhance bone formation.
Market key trends:
One of the key trends in the dental membrane and bone graft substitute market is the increasing popularity of bone graft substitutes over autologous bone grafts. Bone graft substitutes offers various advantages over traditional autologous bone grafts such as reduced morbidity at the donor site, avoids additional surgeries, and increased volume of graft material. Moreover, bone graft substitutes have enhanced osteoinductive and osteoconductive properties due to recent innovations and new product launches across the market.
SWOT Analysis
Strength: Wide range of membrane and bone grafting products with different properties to match various clinical needs. Presence of several industry leaders with strong geographic presence.
Weakness: High price of advanced bone graft substitutes and dental membranes which limits their adoption in developing regions.
Opportunity: Increasing prevalence of dental diseases, rising dental tourism in emerging markets. Launch of bioactive membranes and bone grafts with improved healing properties.
Threats: Stringent regulatory approval process delays time to market. Threat from alternative treatments like guided tissue regeneration.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period 2023 to 2030 due to increasing number of dental implants and rise in edentulous population worldwide.
The North America region currently dominates the market and is expected to continue its dominance over the forecast period owing to growing awareness regarding oral health and availability of advanced dental procedures.
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
